Rehabilitation and Survivorship Considerations in Head and Neck Cancer
Dr. Ron Karni shares best practices for assessing, diagnosing and treating head and neck lymphedema (HNL) using case studies and recent clinical data.
- Pre-rehabilitation and rehabilitation are increasingly emphasized in cancer care.
- Lymphedema is the cardinal side effect of HN cancer treatment.
- Flexitouch® is the only FDA-approved device for managing HNL.
Click the timestamps below to jump to video segments on YouTube:
0:00 – Intro / the changing demographic of HNC patients
6:39 Side effects from head and neck cancer
9:39 Rehabilitation team and managing cancer care
13:15 Cancer treatment: Doctor vs. Patient perspectives
18:20 Importance of prehab, rehabilitation, and lymphedema therapy for HNC survivors
22:50 Only 15% of survivors utilize lymphedema therapy
23:47 Five key things to know about lymphedema
29:29 How to identify and measure lymphedema
34:45 Patient examples: internal lymphedema
41:39 Challenges with traditional lymphedema care
43:02 Why patients need the Flexitouch device
45:56 Vanderbilt Clinical Trial – the first RCT for HN Lymphedema
54:58 How does external treatment help internal swelling?
57:05 When to refer patients for the Flexitouch?
59:29 How can you diagnose lymphedema if you are not measuring internally?
1:02:42 Dr. Karni shares what he has seen with the Flexitouch